Pharmaceutical Supply – Ciprofloxacin Hydrochloride in Dextrose

The Defense Logistics Agency has awarded a subcontract for the supply of one unit of sterile intravenous antibiotic solution, specifically Ciprofloxacin Hydrochloride in Dextrose, to support U.S. Navy submarine outfitting operations. The contract is classified under NAICS code 325412, indicating it pertains to pharmaceutical and biological product manufacturing, and is part of a broader defense medical supply chain effort. The item must meet strict sterility and quality standards appropriate for deployment in austere or remote maritime environments where prompt medical intervention may be required. Delivery is targeted to a U.S. Navy submarine outfitting site, although the precise location is not specified in the data. The contract was posted on July 16, 2026, and is managed under the DLA’s procurement system with the referenced contract and delivery identification numbers. While there is no set-aside designation or solicitation number provided, the contract reflects routine logistical support for military healthcare preparedness, ensuring frontline medical readiness through the timely availability of essential antimicrobial agents.